Halozyme Therapeutics, Inc. (HALO)

Last Closing Price: 110.19 (2026-09-04)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Halozyme Therapeutics, Inc. (HALO) Expense Ratio data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$481.00M
$229.91M
$79.17M
$401.83M
$193.34M
$287.65M
$-2.75M
$284.90M
$284.90M
$229.91M
$229.91M
$229.91M
$229.91M
$287.65M
$323.27M
117.27M
121.22M
$1.96
$1.90
Balance Sheet Financials
$933.02M
$84.27M
$1.64B
$2.58B
$344.44M
$1.94B
$2.09B
$2.43B
$143.54M
$-1.36B
$143.54M
114.04M
Cash Flow Statement Financials
$420.97M
$-65.54M
$-327.86M
$136.42M
$163.99M
$27.57M
$34.34M
--
--
Fundamental Metrics & Ratios
2.71
--
--
0.93
14.95
83.54%
59.80%
59.80%
--
59.23%
47.80%
$413.06M
--
Expense Ratio
--
--
0.19
0.58
1.06
85.29
160.17%
-16.90%
8.92%
11.05%
$1.26
$3.41
$3.47